PTGS2 and Behcet disease: Another study similarly found that baseline CRP levels were significantly higher in individuals with BD than in healthy volunteers, and that individuals with BD treated with adjunctive cyclooxygenase-2 (COX-2) inhibitors had significantly lower CRP levels than those who received placebo (Edberg et al., 2018).